Clinical Trials Directory

Trials / Unknown

UnknownNCT02208414

Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques

A Randomized Double-Blind Placebo-Controlled Crab Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques in NTU Campus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Purpose of this study is to determine whether NAET procedures are effective in the treatment of crab or shrimp allergy. Hypothesis: experimental group will show a significant improvement over the control group in allergic symptom, serum crab- or shrimp-specific IgE and skin test for crab or shrimp extract.

Detailed description

Nambudripad allergy elimination techniques (NAET) were developed by Dr. Devi Nambudripad in 1983. Many patients have been relieved of allergy and allergy-related disease by this treatment. Lack of well-controlled clinical study prevents NAET from being accepted as a treatment option in current medical system. The aim of this project is to conduct a double blind-placebo controlled study of applying NAET to treat crab or shrimp allergy. The parameters to be measured are allergic symptom, crab- or shrimp-specific IgE and skin test before and after NAET treatment

Conditions

Interventions

TypeNameDescription
PROCEDURENAETNAET with acupressure and/or chiropractic procedures with the participant holding crab and shrimp energy signature vial
PROCEDURENAETNAET with acupressure and/or chiropractic procedures with the participant holding water vial

Timeline

Start date
2012-06-01
Primary completion
2014-07-01
Completion
2014-12-01
First posted
2014-08-05
Last updated
2014-08-05

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02208414. Inclusion in this directory is not an endorsement.